Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

Philippe Moreau; Meletios A. Dimopoulos; Paul G. Richardson; David S. Siegel; Michele Cavo; Paolo Corradini; Katja Weisel; Michel Delforge; Peter O'Gorman; Kevin Song; Christine Chen; Nizar Bahlis; Albert Oriol; Markus Hansson; Martin Kaiser; Pekka Anttila; Reinier Raymakers; Cristina Joao; Gordon Cook; Lars Sternas; Tsvetan Biyukov; Ana Slaughter; Kevin Hong; Jennifer Herring; Xin Yu; Mohamed Zaki; Jesus San-Miguel

doi:10.1111/ejh.12903

Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

Philippe Moreau, Meletios A. Dimopoulos, Paul G. Richardson, David S. Siegel, Michele Cavo, Paolo Corradini, Katja Weisel, Michel Delforge, Peter O'Gorman, Kevin Song, Christine Chen, Nizar Bahlis, Albert Oriol, Markus Hansson, Martin Kaiser, Pekka Anttila, Reinier Raymakers, Cristina Joao, Gordon Cook, Lars SternasTsvetan Biyukov, Ana Slaughter, Kevin Hong, Jennifer Herring, Xin Yu, Mohamed Zaki, Jesus San-Miguel

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	European Journal of Haematology
Vuosikerta	99
Numero	3
Sivut	199-206
Sivumäärä	8
ISSN	0902-4441
DOI - pysyväislinkit	https://doi.org/10.1111/ejh.12903
Tila	Julkaistu - syysk. 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1111/ejh.12903

Siteeraa tätä

Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., ... San-Miguel, J. (2017). Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis. European Journal of Haematology, 99(3), 199-206. https://doi.org/10.1111/ejh.12903

@article{810ffb40c7ac43b2b9ddf1a7aab06f3e,

title = "Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis",

keywords = "dexamethasone, pomalidomide, pooled analysis, relapsed and refractory multiple myeloma, safety, CONSENSUS STATEMENT, RENAL IMPAIRMENT, LENALIDOMIDE, BORTEZOMIB, EFFICACY, SAFETY, MM-003, 3122 Cancers",

author = "Philippe Moreau and Dimopoulos, {Meletios A.} and Richardson, {Paul G.} and Siegel, {David S.} and Michele Cavo and Paolo Corradini and Katja Weisel and Michel Delforge and Peter O'Gorman and Kevin Song and Christine Chen and Nizar Bahlis and Albert Oriol and Markus Hansson and Martin Kaiser and Pekka Anttila and Reinier Raymakers and Cristina Joao and Gordon Cook and Lars Sternas and Tsvetan Biyukov and Ana Slaughter and Kevin Hong and Jennifer Herring and Xin Yu and Mohamed Zaki and Jesus San-Miguel",

year = "2017",

month = sep,

doi = "10.1111/ejh.12903",

language = "English",

volume = "99",

pages = "199--206",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "Wiley",

number = "3",

}

Moreau, P, Dimopoulos, MA, Richardson, PG, Siegel, DS, Cavo, M, Corradini, P, Weisel, K, Delforge, M, O'Gorman, P, Song, K, Chen, C, Bahlis, N, Oriol, A, Hansson, M, Kaiser, M, Anttila, P, Raymakers, R, Joao, C, Cook, G, Sternas, L, Biyukov, T, Slaughter, A, Hong, K, Herring, J, Yu, X, Zaki, M & San-Miguel, J 2017, 'Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis', European Journal of Haematology, Vuosikerta 99, Nro 3, Sivut 199-206. https://doi.org/10.1111/ejh.12903

Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis. / Moreau, Philippe; Dimopoulos, Meletios A.; Richardson, Paul G. et al.
julkaisussa: European Journal of Haematology, Vuosikerta 99, Nro 3, 09.2017, s. 199-206.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone

T2 - A pooled analysis

AU - Moreau, Philippe

AU - Dimopoulos, Meletios A.

AU - Richardson, Paul G.

AU - Siegel, David S.

AU - Cavo, Michele

AU - Corradini, Paolo

AU - Weisel, Katja

AU - Delforge, Michel

AU - O'Gorman, Peter

AU - Song, Kevin

AU - Chen, Christine

AU - Bahlis, Nizar

AU - Oriol, Albert

AU - Hansson, Markus

AU - Kaiser, Martin

AU - Anttila, Pekka

AU - Raymakers, Reinier

AU - Joao, Cristina

AU - Cook, Gordon

AU - Sternas, Lars

AU - Biyukov, Tsvetan

AU - Slaughter, Ana

AU - Hong, Kevin

AU - Herring, Jennifer

AU - Yu, Xin

AU - Zaki, Mohamed

AU - San-Miguel, Jesus

PY - 2017/9

Y1 - 2017/9

KW - dexamethasone

KW - pomalidomide

KW - pooled analysis

KW - relapsed and refractory multiple myeloma

KW - safety

KW - CONSENSUS STATEMENT

KW - RENAL IMPAIRMENT

KW - LENALIDOMIDE

KW - BORTEZOMIB

KW - EFFICACY

KW - SAFETY

KW - MM-003

KW - 3122 Cancers

U2 - 10.1111/ejh.12903

DO - 10.1111/ejh.12903

M3 - Article

SN - 0902-4441

VL - 99

SP - 199

EP - 206

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 3

ER -